Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of September 2025, with a specific report date of September 22, 2025. The filing serves to disseminate a press release regarding the presentation of clinical results for the Company's ProSense® cryoablation technology at the CIRSE 2025 Annual Meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on clinical developments rather than a financial statement.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary update is the presentation of positive clinical results from four independent studies at a major medical conference.
Guidance, Outlook, and Management Commentary
Management highlighted the feature of the ProSense® system at the CIRSE 2025 Annual Meeting. The press release incorporated by reference details positive clinical outcomes from four independent studies. The filing does not contain specific financial guidance, risk factor updates, or discussion of contingencies beyond the standard incorporation of the press release into existing registration statements.
Investor Verification Checklist
- Verify the specific clinical endpoints and statistical significance of the four independent studies presented at CIRSE 2025.
- Review the full text of the press release (Exhibit 99.1) for details on the ProSense® technology performance.
- Confirm the impact of these clinical results on the Company's regulatory strategy and commercialization timeline.
- Check subsequent filings for any financial updates or changes in guidance resulting from the conference presentation.